Viewing Study NCT03517956

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2026-06-08 @ 7:31 PM
Study NCT ID: NCT03517956
Status: COMPLETED
Last Update Posted: 2022-07-14
First Post: 2018-05-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid Tumors
Sponsor: Bayer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced or Metastatic Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None Locally advanced or metastatic solid tumor View
None Urothelial cancer View
None FGFR inhibitor View